QL
DNLI icon

Quarry LP’s Denali Therapeutics DNLI Stock Holding History

Quarry LP’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,000
Closed -$116K – 1640
2025
Q4 		$116K Buy
7,000
+2,625
+60% +$44.3K 0.02% 395
2025
Q3 		$63.5K Buy
+4,375
New +$62.9K 0.01% 718
2024
Q3 		– Sell
-6,500
Closed -$151K – 1741
2024
Q2 		$151K Sell
6,500
-500
-7% -$9.6K 0.04% 224
2024
Q1 		$144K Buy
+7,000
New +$132K 0.03% 202

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quarry LP's DNLI Position: Q1 2026 in Review

Quarry LP sold out of Denali Therapeutics (DNLI) in Q1 2026, closing a stake of 7,000 shares — an estimated $116K sold.

Quarry LP first reported a position in DNLI in Q1 2024 and held it in 4 quarters. The position peaked at $151K in Q2 2024. 269 funds tracked by Wall St. Rank hold DNLI as of Q1 2026.

  • Quarry LP reported no remaining Denali Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 7,000 Denali Therapeutics shares in Q1 2026, an estimated $116K.
  • Quarry LP first reported a position in Denali Therapeutics in Q1 2024 and held it in 4 quarters.
  • Quarry LP's Denali Therapeutics position peaked at $151K in Q2 2024.
  • 269 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.